Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artículo biblioteca |
| Language: | eng |
| Published: |
ST-Bio-Life LLC
2021
|
| Subjects: | MELATONINA, SARS-CoV-19, VARIANTE DELTA COVID-19, VARIANTES FUTURAS, |
| Online Access: | https://repositorio.uca.edu.ar/handle/123456789/13671 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
oai:ucacris:123456789-13671 |
|---|---|
| record_format |
koha |
| spelling |
oai:ucacris:123456789-136712022-03-23T05:01:00Z Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus. 2022-03-22T13:57:48Z 2022-03-22T13:57:48Z 2021 Artículo Reiter, R.J. et al. Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 [en línea]. Melatonin Research. 2021, 4 (3). doi: 10.32794/mr112500107. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13671 2641-0281 (online) https://repositorio.uca.edu.ar/handle/123456789/13671 10.32794/mr112500107 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf ST-Bio-Life LLC Melatonin Research Vol. 4, No.3, 2021 |
| institution |
UCA |
| collection |
DSpace |
| country |
Argentina |
| countrycode |
AR |
| component |
Bibliográfico |
| access |
En linea |
| databasecode |
dig-uca |
| tag |
biblioteca |
| region |
America del Sur |
| libraryname |
Sistema de bibliotecas de la UCA |
| language |
eng |
| topic |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS |
| spellingShingle |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| description |
Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective
against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus. |
| format |
Artículo |
| topic_facet |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS |
| author |
Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan |
| author_facet |
Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan |
| author_sort |
Reiter, Russel J. |
| title |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_short |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_full |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_fullStr |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_full_unstemmed |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_sort |
rationale for the continued use of melatonin to combat the delta variant of sars-cov-2 |
| publisher |
ST-Bio-Life LLC |
| publishDate |
2021 |
| url |
https://repositorio.uca.edu.ar/handle/123456789/13671 |
| work_keys_str_mv |
AT reiterrusselj rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT cardinalidanielpedro rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT neelrichardl rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT dominguezrodriguezalberto rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT browngregorym rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT tesarikjan rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 |
| _version_ |
1756276477665476608 |